Metabolism-directed optimization of 3-aminopyrazinone acetamide thrombin inhibitors. Development of an orally bioavailable series containing P1 and P3 pyridines.

Source:http://linkedlifedata.com/resource/pubmed/id/12570369

J. Med. Chem. 2003 Feb 13 46 4 461-73

Download in:

View as

General Info

PMID
12570369